How Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys

Preview text: How Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys 96 Learn how Nexxys…

Monday, Mar 23, 2026 at 8:07 AM EasternHubSpot

Culture BiosciencesHow Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys

Image not available

No image available for this email.

Subject: How Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys
Preview text: How Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys 96 Learn how Nexxys…
From: contact@culturebiosciences.com
Brand: Culture Biosciences
ESP: HubSpot
Sent: Mon Mar 23, 2026, 8:07 AM ET
Size: 36 KB
Images: 4
Links: 6, 1 of them buttons
Subject length: 70 characters

Against Culture Biosciences's usual

Sent in the 8 AM hour, which holds 24% of its emails; 43% arrive in the 10 AM hour. The subject is 70 characters, the same as its average.

	Apr 21, 2026 11:37 AM	Design DoEs like you use ChatGPT, but with ChatDoE
	Apr 15, 2026 10:31 AM	We Changed Only the Bioreactor—Here’s What Happened to Titer and VCD
	Apr 7, 2026 12:02 PM	New Blog: Break Free from the Bioprocess Juggling Act
	Mar 30, 2026 8:05 AM	22,000 bioreactor runs have taught us a thing or two
	Mar 23, 2026 8:07 AM	How Virica Biotech Boosted AAV Titers with Culture Bioscience’s Nexxys (this email)
	Mar 16, 2026 8:01 AM	Break away from traditional bioprocessing with mobile, cloud-connected bioprocessing solutions
	Mar 16, 2026 8:01 AM	Get to Know Culture Biosciences and Accelerate Process Development